Chemotherapy and the risk of extravasation

Similar documents
Basal cell carcinoma. Skin Oncology Team Patient Information Leaflet

Varicose vein treatment radiofrequency ablation (ClosureFast)

Qutenza. Pain Management Team Patient Information Leaflet

Advice after minor skin surgery or cautery using local anaesthetic. Dermatology Department Patient Information Leaflet

Local steroid injections to joints and soft tissues

Endoscopic ultrasound scan

Gastroscopy and dilatation/stent insertion

Intravenous anti-cancer treatment

Having a renal biopsy

Pexact gastrostomy. GI Unit. Patient Information Leaflet

Surgical treatment for Dupuytren s disease

Lengthening of the penile frenulum

CT urogram. Radiology Department Patient Information Leaflet

Gynaecology Department Patient Information Leaflet

Gastroscopy. GI Unit Patient Information Leaflet

Sacroiliac joint injections

Having a nephrostomy tube inserted

Melanoma in situ. Skin Oncology Team Patient Information Leaflet

Spinal cord compression

Spinal cord stimulation

Patch testing. Dermatology Department Patient Information Leaflet

Patient Information Cataract Surgery

Collagenase injections for Dupuytren s disease

CT guided lung biopsy explained

Occipital nerve block

Operation to remove the tonsils

Pain relief after day surgery

Infliximab infusion for patients with Crohn s disease. GI Unit Patient Information Leaflet

What is a hydrocele? It is a swelling caused by a build-up of fluid in the fluid sac surrounding the testicle. It is very common.

Parent/Carer Information Leaflet

Cystoscopy and insertion of a ureteric stent

Gestational diabetes. Maternity Department Patient Information Leaflet

Cystoscopy and hydrostatic bladder distension

Department of Renal Medicine Patient Information Leaflet

Treatment FLAG. An information guide

The temporary haemodialysis catheter

Patient Information Fundus fluorescein angiography

MRI scan. Radiology Department Patient Information Leaflet

Familial hypercholesterolaemia screening

Understanding compression bandages. Leg Ulcer Management Team Patient Information Leaflet

Advice for patients after laparoscopic hernia repair

Treating narrowing of the urethra

Lumbar sympathetic block. Pain Management Patient Information Leaflet

Advice for patients after hernia repair

Hemiarthroplasty (half hip replacement)

The peritoneal dialysis catheter

CT scan chest and upper abdomen

Indwelling pleural drainage system explained

The arteriovenous fistula for haemodialysis

Endoscopic bronchial ultrasound

Pain relief for children

Ganglion impar block. Pain Management Patient Information Leaflet

Intrathecal drug delivery system

Radiotherapy Treatment of Brain Cancer

Having a lumbar puncture

Duloxetine for the treatment of pain

Transforaminal epidural injections

Department of Clinical Haematology. Chemotherapy. Information for patients. Page 1 of 12

Treatment FLAG-IDA. An information guide

Gynaecology Department Patient Information Leaflet

Bacterial meningitis

Radiological insertion of a nephrostomy and ureteric stent. An information guide

Short course radiotherapy for lung cancer

Superior hypogastric plexus block. Pain Management Patient Information Leaflet

Angiogram. Information for patients

Lung Investigation Service Patient Information Leaflet

Treatment FLAG. An information guide

Haemodialysis access with an arteriovenous fistula

Clostridium difficile

Gemcitabine and Cisplatin (urology)

Urinary incontinence. Urology Department. Patient Information Leaflet

Prostate Artery Embolisation (PAE)

Radiofrequency ablation of sympathetic nervous system

Endometrial (womb) cancer

Spinal anaesthesia for pain relief after surgery

Edinburgh Cancer Centre, Western General Hospital. Understanding Epirubicin, Oxaliplatin & 5-Fluorouracil Chemotherapy (EOF)

Rheumatology Department Patient Information Leaflet. Introduction Prolia (denosumab) is a treatment for post-menopausal osteoporosis.

Understanding compression stockings (hosiery) Leg Ulcer Management Team Patient Information Leaflet

Rheumatology Department Patient Information Leaflet

Department of Haematology & Oncology. Managing extravasation. Drug group: patientinformation. Rotherham Hospital Your health, your choice, our passion

Children s Diabetes Patient Information Leaflet High HbA1c the Surgical Assessment Unit (SAU)

Dynamic hip screw (sliding hip screw)

Treating cancer of the endometrium. Information for patients Gynaecology

Patient Information Argon macular laser treatment Introduction

Rheumatology Department Patient Information Leaflet

Doxorubicin & Ifosfamide

Methotrexate. You will have a routine blood test before the start of each cycle of treatment.

Bendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine.

About general anaesthesia Day Surgery Unit Patient Information Leaflet

Northumbria Healthcare NHS Foundation Trust. Corticosteroid Injection Therapy. Issued by Northumbria Healthcare NHS Foundation Trust

Trauma and Orthopaedics Patient Information Leaflet

Mitomycin C and Fluorouracil

Myocrisin (gold) injections. Rheumatology Department Patient Information Leaflet

Having a Testicular (Varicocele) Embolisation

Radiotherapy to the Spine. Information for patients. Northern Centre for Cancer Care Freeman Hospital

Radiotherapy to your breast or chest wall

Vinblastine (Lymphoma)

Having a diagnostic catheter angiogram

About your graft for dialysis. Information for patients Sheffield Kidney Institute (Renal Unit)

Transcription:

Chemotherapy and the risk of extravasation Cancer Service Patient Information Leaflet This leaflet contains important information about your treatment. Please read it and ask us if you have any queries. Introduction This booklet has been written to provide information to patients receiving intravenous chemotherapy about the risk of extravasation. It is not meant to replace the discussion between you, the doctor and the nursing team treating you, but it helps you to understand more about what is discussed. What is extravasation? Extravasation is the term used to describe the leakage of a drug out of the vein into the surrounding tissue which can occur during the administration of chemotherapy or other intravenous drugs. These are drugs given through a cannula into a vein. A cannula is a small, plastic device entering the vein, through which fluids and drugs can be given. The risk of extravasation is very low. It can happen to between one to four people out of every 10 people receiving intravenous chemotherapy.

What causes extravasation? The exact cause is not always clear but we know some people are more at risk than others. These include: Elderly, confused or agitated people People with fragile veins or certain diseases People with a low platelet count (platelets are cells in the blood which help to stop bleeding) People who have already had a lot of chemotherapy treatment through their veins Children Movement of the cannula (small plastic tube situated in a vein) through which treatment is given What are the symptoms? You may notice redness, inflammation or irritation, warmth, pain, stinging or swelling at, or near, the site where the drug enters the vein. Fortunately, more severe symptoms are very rare. However, these can range from superficial tissue/skin reaction, inflammation and blistering of the nearby skin to damage to the underlying tissue and structures, such as muscle and tendons. If you think that you may have an extravasation injury, it is important that you tell your nurse immediately. How is it diagnosed? Extravasation can be difficult to diagnose as some drugs can make veins feel sore without causing lasting damage and other drugs can cause temporary redness or flare around the treatment site. If during the process of being given your treatment, you feel a change in the sensation or anything different in the way the drugs are going into the vein, please tell the chemotherapy staff immediately. It is important to let us know how you really feel so that we can act quickly. 2

If extravasation if confirmed or suspected as having occurred, we will ask you to look at the area once a day to assess whether: The area has changed in colour or increased in redness The area is blistering, peeling or flaking The area is more uncomfortable or tight The pain is making it difficult for you to exercise the arm or hand If the answer is 'yes' to any of the above symptoms, please tell your nurse immediately; or contact us on one of the numbers in this leaflet or on your yellow Chemotherapy Appointment card if you have gone home. You will be assessed by a specialist nurse, doctor and/or pharmacist who will decide what action needs to be taken. You will also be asked for your consent to take a digital image (photograph) of the affected area so that we can monitor your progress. This will be retained in your hospital notes. You will also be asked to return to the unit for a specialist doctor or nurse to examine the affected area, the next working day after the extravasation injury. How is it treated? The Dudley Group NHS Foundation Trust has a clear policy on the management of extravasation and the treatment required for the different drugs used. All staff working on the chemotherapy unit receive regular training on extravasation recognition and management. If you experience extravasation, you may be asked to continue some treatment when you go home. The doctor or nurse will advise you on what you need to do. This can involve applying a cream to the area (depending on which drug has leaked), applying a warm or cold pack to the affected area, keeping the affected arm raised where possible, gently exercising the affected arm or hand and taking painkillers if needed. 3

The treatment for extravasation can also make the affected area uncomfortable. You might need to apply cream or ointment; hot or cold packs and take painkillers for a while afterwards. On rare occasions, plastic surgery may be required in the affected area. In this case, the Plastic Surgery team will contact you. Can it be prevented? We can reduce the risk by careful choice of the type of cannula used (this is a small device entering the vein, through which fluids and drugs can be given) and where it is placed in the hand or arm. The possibility of extravasation occurring cannot be completely prevented, and is a known side effect of intravenous treatment. This is why it is important that you let staff know immediately of any change in the sensation around the cannula whilst the treatment is being given. Prompt action can reduce the damage and discomfort of extravasation. However unfortunately, even with prompt action, certain drugs can cause painful tissue damage. Some patients may need to see a plastic surgeon for assessment. You can help to reduce your risk of getting extravasation by wearing loose fitting clothing when you attend for treatment. This will help to reduce the amount of movement to your hand and arm if you need to use the toilet, and will also reduce the risk of pulling on your cannula or drip. Can I find out more? You can call for more information as follows: C4 Georgina Day Case Unit on: 01384 456111 ext. 2454/2028 (8am to 6pm, Monday to Friday) Ward C4 Georgina Unit (at all other times) on: 01384 244235 or 01384 244258 4

Who do I contact if I have any concerns? If you notice any changes to your skin or experience any pain, redness or swelling around the area that your cannula was placed, please contact these numbers for advice immediately: C4 Georgina Day Case Unit on: 01384 456111 ext. 2454/2028 (8am to 6pm, Monday to Friday) Ward C4 Georgina Unit (at all other times) on: 01384 244235 or 01384 244258 5

Russells Hall Hospital switchboard number: 01384 456111 This leaflet can be downloaded or printed from: http://dudleygroup.nhs.uk/services-and-wards/oncology/ If you have any feedback on this patient information leaflet, please email dgft.patient.information@nhs.net Originator: Allison Field. Date reviewed: September 2017. Next review due: September 2020. Version: 2. DGH ref: DGH/PIL/00606 6